Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1100.30% is 313% below its 3-year average of -266.56%, around the middle of its 3-year range (-1667.19%–0.00%).
24.47% below its 12-month average of -884.01%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1031.72%.
NET PROFIT MARGIN
-1100.30%
NET PROFIT MARGIN AVG TTM
-884.01%
NET PROFIT MARGIN AVG 3Y
-266.56%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-24.47%
CURRENT VS 3Y AVG
-312.78%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 731 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
DataMEDS AI, Inc.
Market Cap
$8.25M
Net Profit Margin
-1100.30%
TTM Avg
-884.01%
3Y Avg
-266.56%
5Y Avg
N/A
Market Cap
$8.05M
Net Profit Margin
0.00%
TTM Avg
-431.21%
3Y Avg
-828.00%
5Y Avg
-552.00%
Market Cap
$8.11M
Net Profit Margin
N/A
TTM Avg
-206582.99%
3Y Avg
-143015.53%
5Y Avg
-102538.66%
Market Cap
$8.53M
Net Profit Margin
-66.29%
TTM Avg
-59.63%
3Y Avg
-44.17%
5Y Avg
-31.01%
Market Cap
$7.96M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.33M
Net Profit Margin
-1977.59%
TTM Avg
-1280.67%
3Y Avg
-1780.71%
5Y Avg
-1415.68%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DataMEDS AI, Inc. (MEDS) | $8.25M | -1100.30% | -884.01% | -266.56% | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.05M | 0.00% | -431.21% | -828.00% | -552.00% |
| HeartSciences Inc. (HSCS)vs › | $8.11M | N/A | -206582.99% | -143015.53% | -102538.66% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | -66.29% | -59.63% | -44.17% | -31.01% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| GT Biopharma, Inc. (GTBP)vs › | $7.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Longeveron Inc. (LGVN)vs › | $7.33M | -1977.59% | -1280.67% | -1780.71% | -1415.68% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.18M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-347.9%
Net Profit Margin
-1100.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1031.72% |
| 2026-03-31 | -496.46% |
| 2025-12-31 | -1667.19% |
| 2025-09-30 | -1139.04% |
| 2025-06-30 | -85.64% |
| 2025-03-31 | -298.53% |
| 2024-12-31 | -34.90% |
| 2024-09-30 | -32.91% |
| 2024-06-30 | -22.84% |
| 2024-03-31 | -22.35% |
| 2023-12-31 | -34.32% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |